PMID- 23835040 OWN - NLM STAT- MEDLINE DCOM- 20140404 LR - 20130813 IS - 1879-1379 (Electronic) IS - 0022-3956 (Linking) VI - 47 IP - 10 DP - 2013 Oct TI - Effects of doxycycline on depressive-like behavior in mice after lipopolysaccharide (LPS) administration. PG - 1521-9 LID - S0022-3956(13)00191-X [pii] LID - 10.1016/j.jpsychires.2013.06.008 [doi] AB - Current evidences support inflammation, oxidative and nitrogen stress, as well as brain-derived neurotrophic factor (BDNF) signaling mechanisms as important in depression pathophysiology. Tetracycline antibiotics have anti-inflammatory and antioxidant properties. Preliminary evidence indicates that minocycline has antidepressant properties. Doxycycline (DOXY) has favorable pharmacokinetic and safety profiles when compared to other tetracycline congeners. The antidepressant activity of DOXY has not been adequately investigated. This study evaluated the effects of DOXY (25 and 50 mg/kg, i.p.) on LPS-induced (0.5 mg/kg, i.p.) depressive-like behavior. Doxycycline was administered 30 min before LPS (pre-LPS) or 1.5 and 23.5 h following LPS (post-LPS) administration in mice. LPS-treated animals presented an increase in immobility time in the forced swimming test (FST) when compared to controls 24 h after endotoxin administration. Similarly to imipramine (IMI-10 mg/kg, i.p.), DOXY at both doses prevented and reversed LPS-induced alterations in the FST. IL-1beta content was increased 24 h after LPS administration in striatum, hippocampus and prefrontal cortex. IMI and DOXY prevented and reversed LPS-induced increase in IL-1beta. IMI and DOXY also prevented and reversed LPS-induced alterations in nitrite content and oxidative stress parameters (lipid peroxidation and reduced glutathione levels). Both DOXY and IMI prevented LPS-induced decrease in hippocampal BDNF levels. Taken together, our results demonstrate that DOXY is comparable to IMI in effectively ameliorate LPS-induced depressive-like behavior, providing a rationale for testing DOXY's antidepressant efficacy in humans. CI - Copyright (c) 2013 Elsevier Ltd. All rights reserved. FAU - Mello, Bruna Stefania Ferreira AU - Mello BS AD - Neuropharmacology Laboratory, Department of Physiology and Pharmacology, Faculty of Medicine, Federal University of Ceara, Fortaleza, CE, Brazil. FAU - Monte, Aline Santos AU - Monte AS FAU - McIntyre, Roger S AU - McIntyre RS FAU - Soczynska, Joanna K AU - Soczynska JK FAU - Custodio, Charllyany Sabino AU - Custodio CS FAU - Cordeiro, Rafaela Carneiro AU - Cordeiro RC FAU - Chaves, Joao Henrique AU - Chaves JH FAU - Vasconcelos, Silvania Maria Mendes AU - Vasconcelos SM FAU - Nobre, Helio Vitoriano Jr AU - Nobre HV Jr FAU - Florenco de Sousa, Francisca Clea AU - Florenco de Sousa FC FAU - Hyphantis, Thomas N AU - Hyphantis TN FAU - Carvalho, Andre Ferrer AU - Carvalho AF FAU - Macedo, Danielle Silveira AU - Macedo DS LA - eng PT - Journal Article PT - Randomized Controlled Trial PT - Research Support, Non-U.S. Gov't DEP - 20130706 PL - England TA - J Psychiatr Res JT - Journal of psychiatric research JID - 0376331 RN - 0 (Antidepressive Agents) RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Interleukin-1beta) RN - 0 (Lipopolysaccharides) RN - 0 (Nitrites) RN - 0 (Thiobarbituric Acid Reactive Substances) RN - 0 (Tumor Necrosis Factor-alpha) RN - GAN16C9B8O (Glutathione) RN - N12000U13O (Doxycycline) SB - IM MH - Animals MH - Antidepressive Agents/*therapeutic use MH - Brain/drug effects/metabolism MH - Brain-Derived Neurotrophic Factor/metabolism MH - Depression/*chemically induced/*drug therapy/pathology MH - Disease Models, Animal MH - Dose-Response Relationship, Drug MH - Doxycycline/*therapeutic use MH - Exploratory Behavior/drug effects MH - Gene Expression Regulation/drug effects MH - Glutathione/metabolism MH - Interleukin-1beta/metabolism MH - Lipopolysaccharides/*toxicity MH - Male MH - Mice MH - Nitrites/metabolism MH - Statistics, Nonparametric MH - Swimming/psychology MH - Thiobarbituric Acid Reactive Substances/metabolism MH - Tumor Necrosis Factor-alpha/metabolism OTO - NOTNLM OT - Depression OT - Doxycycline OT - Lipopolysaccharide OT - Neuroinflammation OT - Oxidative stress EDAT- 2013/07/10 06:00 MHDA- 2014/04/05 06:00 CRDT- 2013/07/10 06:00 PHST- 2013/03/28 00:00 [received] PHST- 2013/06/01 00:00 [revised] PHST- 2013/06/14 00:00 [accepted] PHST- 2013/07/10 06:00 [entrez] PHST- 2013/07/10 06:00 [pubmed] PHST- 2014/04/05 06:00 [medline] AID - S0022-3956(13)00191-X [pii] AID - 10.1016/j.jpsychires.2013.06.008 [doi] PST - ppublish SO - J Psychiatr Res. 2013 Oct;47(10):1521-9. doi: 10.1016/j.jpsychires.2013.06.008. Epub 2013 Jul 6.